CoChat
Sign Up
Cited by 119

The broader economic impact of vaccination: reviewing and appraising the strength of evidence

Jit, Mark, Hutubessy, Raymond, Png, May Ee, Sundaram, Neisha, Audimulam, Jananie, Salim, Safiyah, Yoong, Joanne·2015·BMC Medicine
DOI 10.1186/s12916-015-0446-9PMC PMC4558933
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-015-0446-9

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • We did not include the downstream benefit of vaccination on non-communicable disease mortality (eg, of diarrhoea on malnutrition), nor broader economic benefit or community development gains that vaccination might facilitate, since the magnitude of causal attribution is more difficult to quantify.

    “We did not include the downstream benefit of vaccination on non-communicable disease mortality (eg, of diarrhoea on malnutrition), nor broader economic benefit or community development gains that vaccination might facilitate, since the magnitude of causal attribution is more difficult to quantify.30”

    From Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization (2024) · cites this paper as [30]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 39

  1. [2]Plotkin SA Vaccines: past, present and future Nat Med. 2005 11 S5 S11 10.1038/nm1209 15812490 PMC7095920 · DOI
  2. [3]Leach-Kemon K Graves CM Johnson EK Lavado RF Hanlon M Haakenstad A Vaccine resource tracking systems BMC Health Serv Res. 2014 14 421 10.1186/1472-6963-14-421 25246005 PMC4263052 · DOI
  3. [4]Kim S-Y Goldie SJ Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches Pharmacoeconomics. 2008 26 191 215 10.2165/00019053-200826030-00004 18282015 · DOI
  4. [6]Belli PC Bustreo F Preker A Investing in children’s health: what are the economic benefits? Bull World Health Organ 2005 83 777 84 16283055 PMC2626422
  5. [7]Bärnighausen T Bloom DE Canning D O’Brien J Accounting for the full benefits of childhood vaccination in South Africa S Afr Med J. 2008 98 844 6 19177886
  6. [8]Bärnighausen T Bloom DE Cafiero-Fonseca ET O’Brien JC Valuing vaccination Proc Natl Acad Sci U S A. 2014 111 12313 9 10.1073/pnas.1400475111 25136129 PMC4151736 · DOI
  7. [9]Bärnighausen T Bloom D Canning D Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type B vaccine Vaccine. 2011 29 2371 80 10.1016/j.vaccine.2010.11.090 21159324 · DOI
  8. [10]Deogaonkar R Hutubessy R van der Putten I Evers S Jit M Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries BMC Public Health. 2012 12 878 10.1186/1471-2458-12-878 23072714 PMC3532196 · DOI
  9. [11]Ozawa S Mirelman A Stack ML Walker DG Levine OS Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review Vaccine. 2012 31 96 108 10.1016/j.vaccine.2012.10.103 23142307 · DOI
  10. [13]Gavi Internal review on wider economic benefits of vaccines. Board Retreat Paper 2012 Geneva Gavi
  11. [14]Insinga RP Dasbach EJ Allen SE Carides GW Myers ER Reductions in Human Papillomavirus-disease resource use and costs with quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study economic evaluation Value Health. 2008 11 1524 4733 10.1111/j.1524-4733.2008.00342.x 18489503 · DOI
  12. [15]Luce B Zangwill K Palmer C Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children Pediatrics. 2001 108 E24 10.1542/peds.108.2.e24 11483834 · DOI
  13. [16]Loeb M Russell M Moss L Fonseca K Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial JAMA. 2010 303 943 50 10.1001/jama.2010.250 20215608 · DOI
  14. [17]Sur D Lopez AL Kanungo S Paisley A Manna B Ali M Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial Lancet. 2009 374 1694 702 10.1016/S0140-6736(09)61297-6 19819004 · DOI
  15. [18]Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell; 2008.
  16. [19]Bloom DE Canning D Seiguer E The effect of vaccination on children’s physical and cognitive development in the Philippines. PGDA Working Papers, Program on the Global Demography of Aging 2011 Cambridge Harvard University
  17. [20]Canning D Razzaque A Driessen J The effect of maternal tetanus immunization on children’s schooling attainment in Matlab, Bangladesh: follow-up of a randomized trial Soc Sci. 2011 72 1429 36 21507538
  18. [21]Driessen J Razzaque A Walker D Canning D The effect of childhood measles vaccination on school enrollment in Matlab, Bangladesh. PGDA Working Papers, Program on the Global Demography of Aging 2011 Cambridge Harvard University
  19. [25]Bishaia D Koenig M Khan M Measles vaccination improves the equity of health outcomes: evidence from Bangladesh Health Econ. 2003 12 415 9 10.1002/hec.732 12720258 · DOI
  20. [26]Rheingans R Atherly D Anderson J Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness Vaccine. 2012 30 A15 23 10.1016/j.vaccine.2012.01.018 22520124 · DOI
  21. [27]Verguet S Murphy S Anderson B Johansson KA Glass R Rheingans R Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis Vaccine. 2013 31 4902 10 10.1016/j.vaccine.2013.07.014 23871824 · DOI
  22. [29]Edejer TT-T Aikins M Black R Wolfson L Hutubessy R Evans DB Cost effectiveness analysis of strategies for child health in developing countries BMJ. 2005 331 1177 10.1136/bmj.38652.550278.7C 16282378 PMC1285096 · DOI
  23. [30]Udezi W Usifoh C Ihimekpen O Willingness to pay for three hypothetical malaria vaccines in Nigeria Clin Ther. 2010 32 1533 4 10.1016/j.clinthera.2010.07.018 20728765 · DOI
  24. [31]Palanca-Tan R The demand for a dengue vaccine: a contingent valuation survey in Metro Manila Vaccine. 2008 26 914 2 10.1016/j.vaccine.2007.12.011 18206277 · DOI
  25. [32]Sauerborn R Gbangou A Dong H Przyborski JM Lanzer M Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso Scand J Public Health. 2005 33 146 50 15823976
  26. [33]Sah R The effects of child mortality changes on fertility choice and parental welfare J Polit Econ 1991 99 582 606 10.1086/261768 · DOI
  27. [34]Connolly M Postma M Health care as an investment: Implications for an era of ageing populations J Med Mark 2010 10 5 14 10.1057/jmm.2009.43 · DOI
  28. [35]Smith R Keogh-Brown M Barnett T Tait J The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment BMJ. 2009 339 b4571 10.1136/bmj.b4571 19926697 PMC2779854 · DOI
  29. [36]Keogh-Brown M Smith R The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands Eur J. 2010 11 543 54 19997956
  30. [37]Alsan M Bloom DE Canning D The effect of population health on foreign direct investment inflows to low- and middle-income countries World Dev. 2006 34 613 30 10.1016/j.worlddev.2005.09.006 PMC7116922 32287931 · DOI
  31. [38]Knodel J Van de Walle E Lessons from the past: policy implications of historical fertility studies Popul Dev Rev. 1979 5 217 45 10.2307/1971824 · DOI
  32. [39]Dahan M Tsiddon D Demographic transition, income distribution, and economic growth J Econ Growth 1998 3 29 52 10.1023/A:1009769930916 · DOI
  33. [40]Connolly M, Constenla D. Assessing economic benefits for government and society attributed to malaria investment strategies: an exploratory analysis based on malaria vaccination. In: Proceedings of the multilateral initiative on malaria. 2009. www.gmasoln.com/downloads/Malaria.pdf.
  34. [41]Soares R Mortality reductions, educational attainment, and fertility choice Am Econ Rev 2005 95 580 601 10.1257/0002828054201486 29125724 · DOI
  35. [42]Walker DG Hutubessy R Beutels P WHO Guide for standardisation of economic evaluations of immunization programmes Vaccine. 2010 28 2356 9 10.1016/j.vaccine.2009.06.035 19567247 · DOI
  36. [43]Husereau D Drummond M Petrou S Carswell C Moher D Greenberg D Consolidated health economic evaluation reporting standards (CHEERS) statement BMC Med. 2013 11 80 10.1186/1741-7015-11-80 23531108 PMC3607979 · DOI
  37. [44]Caro JJ Briggs AH Siebert U Kuntz KM Modeling good research practices – overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force 1 Value Health. 2012 15 796 803 10.1016/j.jval.2012.06.012 22999128 · DOI
  38. [45]Bhutta ZA Das JK Walker N Rizvi A Campbell H Rudan I Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet. 2013 381 1417 29 10.1016/S0140-6736(13)60648-0 23582723 · DOI · Paper page
  39. [46]Coast J Smith RD Lorgelly P Welfarism, extra-welfarism and capability: the spread of ideas in health economics Soc Sci Med. 2008 67 1190 8 10.1016/j.socscimed.2008.06.027 18657346 · DOI

Cited by

Sorted by citations

Authors
Jit, M., Hutubessy, R., Png, M. E., Sundaram, N., Audimulam, J., Salim, S., & Yoong, J.
Venue
BMC Medicine
Publisher
Springer Science and Business Media LLC
Published
2015-09-03
Volume
13
Issue
1
ISSN
1741-7015
DOI
10.1186/s12916-015-0446-9
PMC
PMC4558933
Cited by
119
References
0
Language
en
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review